作者
Luca Arcari, Michelangelo Luciano, Luca Cacciotti, Maria Beatrice Musumeci, Valerio Spuntarelli, Eleonora Pistella, Dario Martolini, Daniele Manzo, Mariateresa Pucci, Claudio Marone, Serena Melandri, Gerardo Ansalone, Claudio Santini, Paolo Martelletti, Massimo Volpe, Luciano De Biase
发表日期
2020/12
期刊
European Heart Journal Supplements
卷号
22
期号
Supplement_N
页码范围
N65-N79
出版商
Oxford University Press
简介
Aims
myocardial involvement in the course of Coronavirus disease 2019 (COVID-19) pneumonia has been reported, though not fully characterized yet. Aim of the present study is to undertake a joint evaluation of hs-Troponin and natriuretic peptides (NP) in patients hospitalized for COVID-19 pneumonia.
Methods and results
in this multicenter observational study, we analyzed data from n = 111 COVID-19 patients admitted to dedicated “COVID-19” medical units. Hs-Troponin was assessed in n = 103 patients and NP in n = 82 patients on admission; subgroups were identified according to values beyond reference range. increased hs-Troponin and NP were found in 38% and 56% of the cases respectively. As compared to those with normal cardiac biomarkers, these patients were older, had higher prevalence of cardiovascular diseases (CVD) and more severe COVID-19 …